Immunome NDA for Varegacestat Accepted by FDA for DTs
BOTHELL, Wash., July 8, 2026 Immunome, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...
biotech collaboration
Advertisement
Biocytogen Partners Whitehawk on BsADC Cancer Therapies
BOSTON and MORRISTOWN, N.J., July 7, 2026 Biocytogen and Whitehawk Therapeutics have announced a global strategic collaboration to accelerate...
Syntax Bio Teams Up with Mayo Clinic to Advance Diabetes Treatment
CHICAGO, June 10, 2026 Syntax Bio announced a research and development collaboration with Mayo Clinic to accelerate the development...
Alnylam and Inceptive Forge $2B AI-RNAi Discovery Alliance
CAMBRIDGE, Massachusetts, USA & PALO ALTO, California, USA, June 3, 2026 Alnylam Pharmaceuticals and Inceptive Nucleics have announced a...
Adcendo and MSD Expand KEYTRUDA Cancer Trial
COPENHAGEN, Denmark, May 26, 2026 Adcendo ApS has announced a new clinical collaboration and supply agreement with MSD (Merck...
Advertisements
Pluristyx and Qkine Sign Strategic iPSC Distribution Deal
SEATTLE, Washington & CAMBRIDGE, UK, May 1, 2026 Pluristyx and Qkine announced a reciprocal distribution agreement aimed at streamlining...
Alloy and Biogen Partner on Antisense Drug Platform
BOSTON, Massachusetts, United States, April 7, 2026 Alloy Therapeutics Inc. announced a multi-target collaboration and license agreement with Biogen...
Quotient Therapeutics, Merck Sign $2.2B IBD Deal
CAMBRIDGE, MASSACHUSETTS, March 24, 2026 Quotient Therapeutics has announced a multi-year research collaboration with Merck & Co. to discover...
Voro Therapeutics Partners with Daiichi Sankyo on ADCs
SAN DIEGO, CA, March 17, 2026 Voro Therapeutics has announced a research collaboration with Daiichi Sankyo to advance its...
Tenaya–Alnylam $1.13B Deal Targets Heart Disease Genes
South San Francisco, California — March 5, 2026 Tenaya Therapeutics and Alnylam Pharmaceuticals have announced a major research collaboration...
Advertisement
